Search research articles
Contact Us
Filters
Showing results (41-50 of 134) with videos related to
Page
of 14
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
September 30, 2011
Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies
Francesco Crea, Stefania Nobili, Elisa Paolicchi, et al.
Bioorganic & Medicinal Chemistry
|
October 11, 2008
Synthesis of new pyrazolo[5,1-c][1,2,4] benzotriazines, pyrazolo[5,1-c]pyrido[4,3-e][1,2,4] triazines and their open analogues as cytotoxic agents in normoxic and hypoxic conditions
Giovanna Ciciani, Marcella Coronnello, Gabriella Guerrini, et al.
Journal of Inorganic Biochemistry
|
June 5, 2020
Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties
Ida Landini, Lara Massai, Damiano Cirri, et al.
International Journal of Cancer
|
December 10, 2002
Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients
Giuseppe Toffoli, Antonio Russo, Federico Innocenti, et al.
Translational Oncology
|
May 30, 2020
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
Giandomenico Roviello, Alberto D'Angelo, Roberto Petrioli, et al.
Anti-Cancer Drugs
|
June 3, 2005
Cytotoxic activity of 3-nitropyrazolo[5,1-c][1,2,4]benzotriazine derivatives: a new series of anti-proliferative agents
Marcella Coronnello, Giovanna Ciciani, Enrico Mini, et al.
Journal of Inorganic Biochemistry
|
January 8, 2008
Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of action
Angela Casini, Christian Hartinger, Chiara Gabbiani, et al.
BMC Cancer
|
October 24, 2018
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma
Daniele Lavacchi, Stefania Nobili, Marco Brugia, et al.
Critical Reviews in Oncology/Hematology
|
March 16, 2020
An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC)
Alberto D'Angelo, Stefan Bagby, Giulia Di Pierro, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
March 20, 2021
Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand?
Giandomenico Roviello, Giuseppe Aprile, Alberto D'Angelo, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 134) with videos related to
Sort By:
Page
of 14
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
September 30, 2011
Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies
Francesco Crea, Stefania Nobili, Elisa Paolicchi, et al.
Bioorganic & Medicinal Chemistry
|
October 11, 2008
Synthesis of new pyrazolo[5,1-c][1,2,4] benzotriazines, pyrazolo[5,1-c]pyrido[4,3-e][1,2,4] triazines and their open analogues as cytotoxic agents in normoxic and hypoxic conditions
Giovanna Ciciani, Marcella Coronnello, Gabriella Guerrini, et al.
Journal of Inorganic Biochemistry
|
June 5, 2020
Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties
Ida Landini, Lara Massai, Damiano Cirri, et al.
International Journal of Cancer
|
December 10, 2002
Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients
Giuseppe Toffoli, Antonio Russo, Federico Innocenti, et al.
Translational Oncology
|
May 30, 2020
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
Giandomenico Roviello, Alberto D'Angelo, Roberto Petrioli, et al.
Anti-Cancer Drugs
|
June 3, 2005
Cytotoxic activity of 3-nitropyrazolo[5,1-c][1,2,4]benzotriazine derivatives: a new series of anti-proliferative agents
Marcella Coronnello, Giovanna Ciciani, Enrico Mini, et al.
Journal of Inorganic Biochemistry
|
January 8, 2008
Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of action
Angela Casini, Christian Hartinger, Chiara Gabbiani, et al.
BMC Cancer
|
October 24, 2018
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma
Daniele Lavacchi, Stefania Nobili, Marco Brugia, et al.
Critical Reviews in Oncology/Hematology
|
March 16, 2020
An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC)
Alberto D'Angelo, Stefan Bagby, Giulia Di Pierro, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
March 20, 2021
Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand?
Giandomenico Roviello, Giuseppe Aprile, Alberto D'Angelo, et al.
Page
of 14